New prospects in the diagnosis and treatment of immune-mediated inner ear disease
New prospects in the diagnosis and treatment of immune-mediated inner ear disease作者机构：Department of OtolaryngologyHospital El EscorialSan Lorenzo de El Escorial28200 MadridSpain Instituto Antolí-Candela28043 MadridSpain Department of OtorhinolaryngologyHospital Puerta de HierroMajadahonda28222 MadridSpain
出 版 物：《World Journal of Methodology》 (世界方法学杂志)
年 卷 期：2014年第4卷第2期
页 面：91-98页
主 题：Autoimmune inner ear disease Diagnostic tests Biologic therapy agents Gene therapy Stem cells
摘 要：Autoimmune inner ear disease(AIED) represents a very fertile research field and the advancements in the understanding of this disease have a direct application not only in patients affected with this condition but also in other inner ear disorders that share the same injury mechanism, damage to the inner ear hair cells. AIED also presents many challenges that have still to be overcome. Firstly, access to the inner ear is limited, as many interventions such as biopsies can result in great irreversible damage. Secondly, there are no completely specific markers for AIED. Lack of a definitive diagnosis can result in the treatment of patients not affected with the disease and, therefore, no response. Finally, some patients become refractory to glucocorticoids and new therapies are needed. This review offers an overview of the animal models that have contributed to the understanding of AIED pathophysiology, the value of currently available diagnostic tests, and therapeutic options, with a special focus on new therapies for non responders or patients refractory to glucocorticoids. Among these new options for therapy, biological agents have been tested recently, whereas gene and stem celltherapy may have a role in the future. The intratympanic route of administration avoids the systemic side effects associated with currently used drugs, and may become a more frequent approach in the future.
维普期刊数据库